CAS 1092539-44-0
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-n-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide
CAS :Formule :C18H22N4O4Degré de pureté :95%Masse moléculaire :358.3917(-)-2-Amino-1-Ethyl-7-(3-Hydroxy-4-Methoxy-3-Methylbut-1-Yn-1-Yl)-N-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxamide
CAS :(-)-2-Amino-1-Ethyl-7-(3-Hydroxy-4-Methoxy-3-Methylbut-1-Yn-1-Yl)-N-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-CarboxamideDegré de pureté :95%Masse moléculaire :358.39g/mol(Rac)-SAR131675
CAS :<p>(Rac)-SAR131675 is an effective and specific VEGFR-3 inhibitor, which inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells.</p>Formule :C18H22N4O4Degré de pureté :98.34% - 99.1%Couleur et forme :SolidMasse moléculaire :358.392-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide
CAS :Formule :C18H22N4O4Degré de pureté :95%Masse moléculaire :358.398SAR131675
CAS :<p>SAR131675 is a drug that acts as a tyrosine kinase inhibitor. It has been shown to have an effect on the growth of cancer cells and has been shown to be effective in treating inflammatory bowel disease. SAR131675 inhibits the activity of protein tyrosine kinases, which are enzymes that phosphorylate proteins and regulate their biological functions. The drug is selective for certain kinases, such as c-kit, stem cell factor receptor (c-Kit), and platelet-derived growth factor receptor (PDGFR). SAR131675 has been shown to be safe and effective in treating diseases such as cancer or inflammatory bowel disease when administered at an effective dose.</p>Formule :C18H22N4O4Degré de pureté :Min. 95%Masse moléculaire :358.39 g/mol
